TGFB1 and chronic granulomatous disease: Overall, our results indicate that HIF-1α mediates fundamental effects of Tβ4, in the lung and likely in the gut, including LAP and induction of genes involved in the angiogenesis and repair, thus pointing to the Tβ4-HIF-1α axis as a potential therapeutic pathway in CGD.